Peter S. Kim, Director at Entrada Therapeutics, Inc. (TRDA), bought 1,512 shares at $13.75 ($21K) on 2024-03-28, disclosed to the SEC on 2024-04-01.
Open-market purchase of $21k TRDA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TRDA | BUY | 2024-05-10 | $63K | — | Filing → |
| TRDA | BUY | 2024-04-10 | $35K | — | Filing → |
| TRDA | BUY | 2024-03-26 | $123K | — | Filing → |